M. Paprskářová

4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.

P. Fischer, G. Kontopidis, M. Hajdúch, 2006, Journal of medicinal chemistry.

Classical Anticytokinins Do Not Interact with Cytokinin Receptors but Inhibit Cyclin-dependent Kinases*

D. Inzé, T. Schmülling, P. Fischer, 2007, Journal of Biological Chemistry.

The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.

M. Hajdúch, P. Džubák, M. Paprskářová, 2010, Neoplasma.

Synthesis and biological activity of 8-azapurine and pyrazolo[4,3-d]pyrimidine analogues of myoseverin.

M. Strnad, L. Havlícek, V. Kryštof, 2006, European journal of medicinal chemistry.

STRC Deletion is a Frequent Cause of Slight to Moderate Congenital Hearing Impairment in the Czech Republic.

M. Paprskářová, P. Plevova, E. Mrázková, 2017, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Genetic Aetiology of Nonsyndromic Hearing Loss in Moravia-Silesia

M. Paprskářová, J. Zapletalová, P. Plevova, 2018, Medicina.

Functional p53 in cells contributes to the anticancer effect of the cyclin‐dependent kinase inhibitor roscovitine

J. Węsierska‐Gądek, M. Strnad, V. Kryštof, 2009, Journal of cellular biochemistry.